Evaluation of denaturing high performance liquid chromatography (DHPLC) for the mutational analysis of the neurofibromatosis type 1 (NF1) gene

Human Genetics

Volumn 109, Issue 5, 2001, Pages 487-497

  Han, S ^a   Cooper, D N ^a   Upadhyaya, M ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; EXON; GENE CLUSTER; GENE MUTATION; GENETIC ANALYSIS; GENETIC SCREENING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; NEUROFIBROMATOSIS; NUCLEOTIDE SEQUENCE; PATHOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOGENE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS;

BASE SEQUENCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COHORT STUDIES; DNA PRIMERS; EXONS; GENES, NEUROFIBROMATOSIS 1; MUTATION; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES;

EID: 0035177704     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390100594     Document Type: Article

References (41)

1. NF1 mutation analysis using a combined heteroduplex/SSCP approach
2. Watson syndrome: Is it a subtype of type 1 neurofibromatosis?
3. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1
4. Evolutionary comparisons
5. A major segment of neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations
6. Identification and mapping of type 1 neurofibromatosis (NF1) homologous loci
7. Comparison of fluorescent single-strand conformation polymorphism analysis and denaturing high-performance liquid chromatography for detection of EXT1 and EXT2 mutations in hereditary multiple exostoses
8. NF1 microdeletion breakpoints are clustered at flanking repetitive sequences
9. Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain
10. A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC
11. Distribution of 13 truncating mutations in the neurofibromatosis 1 gene
12. Hypermethylation of the neurofibromatosis type 1 (NF1) gene promoter is not a common event in the inactivation of the NF1 gene in NF1-specific tumours
13. High-resolution liquid chromatography of DNA fragments on non-porous poly(styrene-divinylbenzene) particles
14. Optimal temperature selection for mutation detection by denaturing high performance liquid chromatography and comparison to SSCP and heteroduplex analysis
15. Application and evaluation of denaturing HPLC for molecular genetic analysis in tuberous sclerosis
16. Genomic characterization of the neurofibromatosis type 1 gene of Fugu rubripes
17. Neurofibromatosis 1 GTPase activating protein-related domain and its functional significance
18. The NF1 Genetic Analysis Consortium
19. Detection of single-nucleotide polymorphisms with the WAVE DNA fragment analysis system
20. Somatic mutations in the neurofibromatosis type 1 gene in human tumours
21. Genomic organization of the neurofibromatosis 1 gene (NF1)
22. Unequal meiotic crossover: A frequent cause of NF1 microdeletions
23. Mechanism of spreading of the highly related neurofibromatosis type 1 (NF1) pseudogenes on chromosomes 2, 14 and 22
24. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects
25. Signature-based analysis of MET proto-oncogene mutations using DHPLC
26. Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection
27. Evaluation of the protein truncation test and mutation detection in the NF1 gene: Mutation analysis of 15 known and 40 unknown mutations
28. Neurofibromatosis type 1 (NF1): A protein truncation assay yielding identification of mutations in 73% of patients
29. Identification of neurofibromatosis (NF1) homologous loci by direct sequencing fluorescence in-situ hybridization, and PCR amplification of somatic cell hybrids
30. A novel RsaI polymorphism within intron 39 of the neurofibromin type 1 (NF1) gene
31. The NF1 gene as a tumour suppressor
32. Neurofibromatosis conference statement
33. Tandem duplication within a neurofibromatosis type 1 (NF1) family with features of Watson syndrome
34. Analysis of the NF1 gene by temperature gradient gel electrophoresis reveals a high incidence of mutations in exon 4b
35. The mutational spectrum in neurofibromatosis type 1 and its underlying mechanisms
36. Analysis of mutations at the neurofibromatosis type 1 (NF1) locus
37. Mutational and functional analysis of the neurofibromatosis type 1 (NF1) gene
38. Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with learning disability, dysmorphic features and developmental delay
39. Gene structure and expression
40. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus
41. Type 1 neurofibromatosis gene: Identification of a large transcript disrupted in three NF1 patients